Switch to
More onapp

How to use scorecard? Learn more

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹26,723 cr, stock is ranked 293
Moderate RiskStock is 2.37x as volatile as Nifty
1,437.0033.50 (-2.28%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is underpriced but is in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹26,723 cr, stock is ranked 293
Moderate RiskStock is 2.37x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
13.74
PB RatioPB Ratio
4.57
Dividend YieldDiv. Yield
0.64%
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Nov 12, 2024

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320242.162.042.814.130.440.170.721.39
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnDec 9, 2024

Natco Pharma Limited has informed the Exchange regarding Sustainability Report for the year 2023-2024 ''. | Download

Natco Pharma Limited has informed the Exchange regarding Sustainability Report for the year 2023-2024 ''. | Download

Issue of Duplicate Share Certificate 
Announced OnDec 4, 2024

Natco Pharma Limited has informed the Exchange about Issue of Duplicate Share Certificate | Download

Natco Pharma Limited has informed the Exchange about Issue of Duplicate Share Certificate | Download

Cash Dividend 
Ex. DateNov 27, 2024

Interim 2 • Div/Share: ₹ 1.5

See all events